[go: up one dir, main page]

IN192381B - - Google Patents

Info

Publication number
IN192381B
IN192381B IN1292DE2002A IN192381B IN 192381 B IN192381 B IN 192381B IN 1292DE2002 A IN1292DE2002 A IN 1292DE2002A IN 192381 B IN192381 B IN 192381B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Girish Jain
Seetharman Sritharan
Ashok Rampal
Original Assignee
Ranbaxy Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab filed Critical Ranbaxy Lab
Priority to IN1292DE2002 priority Critical patent/IN192381B/en
Priority to CA002511208A priority patent/CA2511208A1/fr
Priority to JP2004561893A priority patent/JP2006512358A/ja
Priority to EP03780445A priority patent/EP1596849A1/fr
Priority to PCT/IB2003/006072 priority patent/WO2004056354A1/fr
Priority to AU2003288604A priority patent/AU2003288604A1/en
Priority to RU2005121999/15A priority patent/RU2005121999A/ru
Priority to BR0317567-7A priority patent/BR0317567A/pt
Priority to CNA2003801094133A priority patent/CN1744889A/zh
Publication of IN192381B publication Critical patent/IN192381B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN1292DE2002 2002-12-20 2002-12-20 IN192381B (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
IN1292DE2002 IN192381B (fr) 2002-12-20 2002-12-20
CA002511208A CA2511208A1 (fr) 2002-12-20 2003-12-18 Compositions pharmaceutiques de tamsulosine a liberation controlee
JP2004561893A JP2006512358A (ja) 2002-12-20 2003-12-18 タムスロシンの放出制御薬剤組成物
EP03780445A EP1596849A1 (fr) 2002-12-20 2003-12-18 Compositions pharmaceutiques de tamsulosine libération controlée
PCT/IB2003/006072 WO2004056354A1 (fr) 2002-12-20 2003-12-18 Compositions pharmaceutiques de tamsulosine a liberation controlee
AU2003288604A AU2003288604A1 (en) 2002-12-20 2003-12-18 Controlled release pharmaceutical compositions of tamsulosin
RU2005121999/15A RU2005121999A (ru) 2002-12-20 2003-12-18 Фармацевтические композиции тамсулозина с контролируемым высвобождением
BR0317567-7A BR0317567A (pt) 2002-12-20 2003-12-18 Composição farmacêutica de liberação controlada de tamsulosina e processo para sua preparação
CNA2003801094133A CN1744889A (zh) 2002-12-20 2003-12-18 坦洛新的控释药物组合物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1292DE2002 IN192381B (fr) 2002-12-20 2002-12-20

Publications (1)

Publication Number Publication Date
IN192381B true IN192381B (fr) 2004-04-10

Family

ID=32676755

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1292DE2002 IN192381B (fr) 2002-12-20 2002-12-20

Country Status (9)

Country Link
EP (1) EP1596849A1 (fr)
JP (1) JP2006512358A (fr)
CN (1) CN1744889A (fr)
AU (1) AU2003288604A1 (fr)
BR (1) BR0317567A (fr)
CA (1) CA2511208A1 (fr)
IN (1) IN192381B (fr)
RU (1) RU2005121999A (fr)
WO (1) WO2004056354A1 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1758903A (zh) * 2003-01-27 2006-04-12 安斯泰来制药有限公司 坦洛新或其盐的肠缓释微粒及其制造方法
EP2112920B1 (fr) 2003-06-26 2018-07-25 Intellipharmaceutics Corp. Capsules contenant un inhibiteur de la pompe a protons comprenant des unites secondaires differemment structurees permettant une liberation retardee de l'ingredient actif
US8394409B2 (en) 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
DK1618873T3 (da) * 2004-07-14 2007-10-08 Siegfried Generics Int Ag Granulat til kontrolleret frigivelse af tamsulosin, indeholdende alginat
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
CN101453996B (zh) * 2006-04-03 2016-05-11 伊萨·奥迪迪 药物递送组合物
EP2007360B1 (fr) 2006-04-03 2014-11-26 Isa Odidi Dispositif d'administration à libération commandée comprenant un enrobage organosol
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
WO2008089593A1 (fr) * 2007-01-18 2008-07-31 Standard Chem. & Pharm. Co., Ltd. Preparation de tamsulosine a liberation prolongee et procede de production associe
WO2010001574A1 (fr) * 2008-07-01 2010-01-07 沢井製薬株式会社 Procédé de production de microparticules sphériques comprenant du chlorhydrate de tamsulosine
CN101695478B (zh) * 2009-10-23 2012-01-18 江苏大学 盐酸坦索罗辛缓释微丸制剂及其制备方法
KR101423237B1 (ko) 2010-05-04 2014-07-30 주식회사 삼양바이오팜 탐스로신 또는 이의 약학적으로 허용 가능한 염을 포함하는 방출 제어용 약학 조성물, 및 이를 포함하는 경구용 제제
CN103315962A (zh) * 2013-02-01 2013-09-25 北京科信必成医药科技发展有限公司 一种坦索罗辛缓释微丸制剂及其制备方法
CN103142492A (zh) * 2013-02-01 2013-06-12 北京科信必成医药科技发展有限公司 一种缓释微丸制剂及其制备方法
CN103919735B (zh) * 2014-05-04 2018-04-17 翰宇药业（武汉）有限公司 一种盐酸坦索罗辛缓释微丸及其制备方法
ES2555485T1 (es) 2014-05-26 2016-01-04 Galenicum Health S.L. Composiciones farmacéuticas que contienen un agente activo
US20190133977A1 (en) * 2016-05-04 2019-05-09 Aspen Park Pharmaceuticals, Inc. Delayed release oral tamsulosin hydrochloride
EP3473244A1 (fr) 2017-10-20 2019-04-24 Veru Inc. Chlorhydrate de tamsulosine à libération contrôlée destiné à être administré par voie orale
EP3473245A1 (fr) 2017-10-20 2019-04-24 Veru Inc. Chlorhydrate de tamsulosine à libération contrôlée destiné à être administré par voie orale
KR20200078146A (ko) * 2018-12-21 2020-07-01 한미약품 주식회사 내산성이 우수한 탐수로신 염산염 함유 제약 조성물 및 이의 제조방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5158777A (en) * 1990-02-16 1992-10-27 E. R. Squibb & Sons, Inc. Captopril formulation providing increased duration of activity
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
EP1064938A1 (fr) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Formes pharmaceutiques à libération contrôlée avec au moins une impulsion temporelle
CA2465110A1 (fr) * 2001-11-07 2003-05-15 Synthon B.V. Comprimes de tamsulosin

Also Published As

Publication number Publication date
EP1596849A1 (fr) 2005-11-23
AU2003288604A1 (en) 2004-07-14
CN1744889A (zh) 2006-03-08
WO2004056354A1 (fr) 2004-07-08
BR0317567A (pt) 2005-11-22
CA2511208A1 (fr) 2004-07-08
JP2006512358A (ja) 2006-04-13
RU2005121999A (ru) 2006-01-20

Similar Documents

Publication Publication Date Title
BE2019C547I2 (fr)
BE2019C510I2 (fr)
BE2018C021I2 (fr)
BE2017C049I2 (fr)
BE2017C005I2 (fr)
BE2016C069I2 (fr)
BE2016C040I2 (fr)
BE2016C013I2 (fr)
BE2015C078I2 (fr)
BE2016C002I2 (fr)
BE2018C018I2 (fr)
BE2015C017I2 (fr)
BE2014C053I2 (fr)
BE2014C051I2 (fr)
BE2014C041I2 (fr)
BE2014C030I2 (fr)
BE2014C016I2 (fr)
BE2014C015I2 (fr)
BE2013C063I2 (fr)
BE2015C069I2 (fr)
JP2003204563A5 (fr)
JP2003106101A5 (fr)
IN192381B (fr)
JP2003198654A5 (fr)
JP2003123382A5 (fr)